Today's Rundown Bristol-Myers teams with BioMotiv to build and buy biotechs Scangos' Vir heading to Wall Street with $100M IPO Versant's Repare raises $82M to trial synthetic lethality drugs Nkarta nets $114M to push natural killer cell therapies into the clinic AstraZeneca to adopt Schrödinger's molecule-modeling platform for drug discovery Cancer drugs' share of new FDA approvals doubled this decade thanks to smarter R&D: report Featured Story | | | Wednesday, September 4, 2019 Bristol-Myers Squibb has allied with biotech accelerator BioMotiv. The deal sets Bristol-Myers up to found and fund biotechs with BioMotiv before going on to acquire them outright once a preclinical candidate is identified. |
|
|---|
|
Top Stories Wednesday, September 4, 2019 Fierce 15 winner Vir Biotechnology, helmed by former Biogen frontman George Scangos, is gunning for a $100 million IPO as it looks to boost its work on infectious diseases and bring Scangos back into Wall Street. Wednesday, September 4, 2019 Repare Therapeutics has raised an $82.5 million series B round to take synthetic lethality drugs into humans. The Versant Ventures-founded biotech plans to start testing ATR inhibitor RP-3500 in the clinic next year. Wednesday, September 4, 2019 Amgen Ventures and Deerfield Management chipped in to a $114 million series B round for Nkarta, which now has the runway to start clinical trials for its natural killer cell therapy, build a manufacturing site and advance its earlier-stage pipeline. Wednesday, September 4, 2019 Schrödinger’s platform aims to predict how strongly a potential drug will bind and affect a target protein with the goal of reducing the number of compounds that need to be synthesized before settling on a lead candidate. Wednesday, September 4, 2019 Pursuing novel mechanisms for treating cancer and validating them with clinical trials has paid off for drug developers, especially as the FDA is speeding up approvals of new treatments for unmet medical needs, a Tufts report concluded. | This week's sponsor is ExL Events. | | | |
Enrollment Showcase | | | October 23-25, 2019 | Chicago, IL | Presented by Biotech Primer BioImmersion: Biotech for the Non-Scientist is a three-day, in-depth course that delves into the scientific details on a broad number of biotechnology topics. Register today! |
|
|---|
|
Resources Sponsored by: Patheon, by Thermo Fisher Scientific Avoid potential risks to the patient as well as costly interruptions during development. Sponsored by: Vineti Developing a cell therapy, gene therapy, or personalized cancer vaccine? Modern data management makes a critical difference in operational and regulatory outcomes. This whitepaper will help your team leverage the latest data strategies for success. Sponsored by: AlphaSense AI-powered research tools are making it easier to source confident healthcare market intelligence with accuracy and efficiency -- download now to learn more about improving your competitive research strategy. Sponsored by: Elemental Machines Your lab is talking to you, are you listening? Sponsored by: Frenova Want to be sure your renal research protocol design is fit for the real world? Sponsored by: Recro Gainesville Vetting CDMOs but unsure what to look for in prospective partners’ multiproduct facilities? Sponsored by: Accenture Clinical trials are one of the pharma industry’s most painful and costly processes. Read how technology could transform the trial process from nine years to a matter of hours. Sponsored by: Baxter BioPharma Solutions Check out Baxter BioPharma Solutions’ whitepaper to learn considerations and options for developing a product in a prefilled syringe. Sponsored by: Alexander Group From sales headcount and budgets to new product launches and saying “yes” to millennials, hear the top 7 topics that are trending in sales compensation. Sponsored by: Wesco Pharmaceutical Solutions and WBR Insights The regulations and managing processes for hazardous, controlled and rare chemicals and biologics necessary for drug discovery are a huge distraction for R&D labs. Learn from the perspectives of industry executives the pain points and improvements they want in their processes for chemicals and biologics in pharmaceuticals R&D. Sponsored by: Kinaxis Download this life sciences industry spotlight to discover how concurrent planning can help you overcome complex supply chain challenges to drive down costs and improve efficiency. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. BioBasics: Biotech For The Non-Scientist Oct 22-23, 2019 | San Diego, CA BioImmersion: Biotech for the Non-Scientist October 23-25, 2019 | Chicago, IL 4th FierceBiotech Drug Development Forum October 28-29, 2019 | Boston, MA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register NOW and start Pre-Boot Camp Preparation! | 